260 related articles for article (PubMed ID: 26882549)
1. Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.
Reyes-Robles T; Lubkin A; Alonzo F; Lacy DB; Torres VJ
EMBO Rep; 2016 Mar; 17(3):428-40. PubMed ID: 26882549
[TBL] [Abstract][Full Text] [Related]
2. Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity.
Tromp AT; Van Gent M; Jansen JP; Scheepmaker LM; Velthuizen A; De Haas CJC; Van Kessel KPM; Bardoel BW; Boettcher M; McManus MT; Van Strijp JAG; Lebbink RJ; Haas PA; Spaan AN
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32041354
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.
Balasubramanian D; Ohneck EA; Chapman J; Weiss A; Kim MK; Reyes-Robles T; Zhong J; Shaw LN; Lun DS; Ueberheide B; Shopsin B; Torres VJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27329753
[TBL] [Abstract][Full Text] [Related]
4. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
[TBL] [Abstract][Full Text] [Related]
5. Unlatching of the stem domains in the Staphylococcus aureus pore-forming leukocidin LukAB influences toxin oligomerization.
Ilmain JK; Perelman SS; Panepinto MC; Irnov I; Coudray N; Samhadaneh N; Pironti A; Ueberheide B; Ekiert DC; Bhabha G; Torres VJ
J Biol Chem; 2023 Dec; 299(12):105321. PubMed ID: 37802313
[TBL] [Abstract][Full Text] [Related]
6. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
Badarau A; Trstenjak N; Nagy E
Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
[TBL] [Abstract][Full Text] [Related]
7. Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.
Spaan AN; van Strijp JAG; Torres VJ
Nat Rev Microbiol; 2017 Jul; 15(7):435-447. PubMed ID: 28420883
[TBL] [Abstract][Full Text] [Related]
8.
Berends ETM; Zheng X; Zwack EE; Ménager MM; Cammer M; Shopsin B; Torres VJ
mBio; 2019 Jan; 10(1):. PubMed ID: 30602580
[No Abstract] [Full Text] [Related]
9. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1.
DuMont AL; Yoong P; Day CJ; Alonzo F; McDonald WH; Jennings MP; Torres VJ
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10794-9. PubMed ID: 23754403
[TBL] [Abstract][Full Text] [Related]
10. Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia.
Tam K; Lacey KA; Devlin JC; Coffre M; Sommerfield A; Chan R; O'Malley A; Koralov SB; Loke P; Torres VJ
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32602902
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha- and gamma-hemolysins and leukocidin.
Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1997 Apr; 61(4):565-72. PubMed ID: 9145511
[TBL] [Abstract][Full Text] [Related]
12. SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins.
Anderson EE; Dyzenhaus S; Ilmain JK; Sullivan MJ; van Bakel H; Torres VJ
Infect Immun; 2023 Apr; 91(4):e0053222. PubMed ID: 36939325
[TBL] [Abstract][Full Text] [Related]
13. Identification of biologic agents to neutralize the bicomponent leukocidins of
Chan R; Buckley PT; O'Malley A; Sause WE; Alonzo F; Lubkin A; Boguslawski KM; Payne A; Fernandez J; Strohl WR; Whitaker B; Lynch AS; Torres VJ
Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651319
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?
Vandenesch F; Lina G; Henry T
Front Cell Infect Microbiol; 2012; 2():12. PubMed ID: 22919604
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.
Scherr TD; Hanke ML; Huang O; James DB; Horswill AR; Bayles KW; Fey PD; Torres VJ; Kielian T
mBio; 2015 Aug; 6(4):. PubMed ID: 26307164
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
Seilie ES; Bubeck Wardenburg J
Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
[TBL] [Abstract][Full Text] [Related]
17. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.
Badarau A; Rouha H; Malafa S; Logan DT; Håkansson M; Stulik L; Dolezilkova I; Teubenbacher A; Gross K; Maierhofer B; Weber S; Jägerhofer M; Hoffman D; Nagy E
J Biol Chem; 2015 Jan; 290(1):142-56. PubMed ID: 25371205
[TBL] [Abstract][Full Text] [Related]
19. Bovine Staphylococcus aureus Secretes the Leukocidin LukMF' To Kill Migrating Neutrophils through CCR1.
Vrieling M; Koymans KJ; Heesterbeek DA; Aerts PC; Rutten VP; de Haas CJ; van Kessel KP; Koets AP; Nijland R; van Strijp JA
mBio; 2015 Jun; 6(3):e00335. PubMed ID: 26045537
[TBL] [Abstract][Full Text] [Related]
20. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
